Arrowhead Pharmaceuticals Inc logo

ARWR - Arrowhead Pharmaceuticals Inc News Story

$26.12 -0.8  -2.9%

Last Trade - 03/04/20

Sector
Healthcare
Size
Mid Cap
Market Cap £2.17bn
Enterprise Value £1.76bn
Revenue £133.4m
Position in Universe 1273rd / 6308

BRIEF-Arrowhead Pharmaceuticals Reports Q1 Loss Per Share $0.03

Wed 5th February, 2020 9:55pm
Feb 5 (Reuters) - Arrowhead Pharmaceuticals Inc  ARWR.O :
    * ARROWHEAD PHARMACEUTICALS REPORTS FISCAL 2020 FIRST
QUARTER
RESULTS
    * QTRLY LOSS PER SHARE $0.03
    * QTRLY REVENUE $29.5 MILLION VERSUS $34.7 MILLION
    * Q1 EARNINGS PER SHARE VIEW $-0.01, REVENUE VIEW $29.5
MILLION --
REFINITIV IBES DATA

Source text for Eikon:  ID:nBw9gLHw6a 
Further company coverage:  ARWR.O 

 ((Reuters.Briefs@thomsonreuters.com;))
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.